| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.003 | 1 |